HOME
News
Oncology Business of Medicine Global Health Health Technology Health Policy
COVID-19 Updates
CME & Education
Community
Meetings & Events Live Broadcasts
Expert Perspectives Professional Organizations Resources
FAQS with Key Opinion Leaders Interviews
All Programs
Clinical Practice Medical Interest CME/CE
Book Club Clinician's Roundtable COVID-19: On The Frontlines Project Oncology®Spotlight on Locum Tenens

Home
Upcoming Events

Targeting TROP2 in EGFR-Mutated Advanced NSCLC: Navigating the ADC Revolution After TKI Failure

Explore the roles of TROP2-directed ADCs in EGFR-mutated advanced NSCLC after TKI failure, with practical guidance on patient selection and toxicity management.

Cancellation Policy

Title

Terms
Privacy
Contact
Cookies

NEED HELP?

Contact us

NEED HELP?

Contact us

Discussion
Player

LIVE ON REACHMD RADIOBack to live radio

ReachMD Radio

00:00

On Air
Playlists

Welcome to the new
Global Oncology Academy website.

NEW FEATURES:

Check out all the new educational programs we have added.New educational programs
Now mobile-friendly and easier to navigate.Now mobile-friendly
A learner profile that stores your history/CME certificates.Track your credits

Tell us what you think by using the Feedback button on the right side of the page.

We're glad to see you're enjoying Global Oncology Academy…
but how about a more personalized experience?

You are now leaving Global Oncology Academy and going to a site run by another organization.

Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.

Cancel Continue

Title

Welcome to the newGlobal Oncology Academy website.

Welcome to the new
Global Oncology Academy website.